News
-
GSK and Theravance have announced that results from three phase 3 studies comparing the Anoro Ellipta umeclidinium/vilanterol DPI to Advair and Seretide Diskus in COPD patients show greater improvement in lung function for patients treated… Read more . . .
-
Alexza Pharmaceuticals has announced that its European partner Ferrer has launched Adasuve loxapine inhalation powder for the treatment of agitation in schizophrenic or bipolar patients in Romania. Ferrer has a distribution agreement with Galenica for… Read more . . .
-
Vectura has announced that it will acquire Activaero for a total of €130 million ($181 million). The company cited both Activaero’s nebulizer technology and its pipeline of respiratory drugs as part of the rationale for… Read more . . .
-
The New York Times has reported that Hunein “John” Maassab, who developed the FluMist intranasal live attenuated influenza vaccine (LAIV), died on February 1, 2014 in North Carolina. Dr. Maassab received a doctorate in epidemiology… Read more . . .
-
According to Hi-Tech Pharmacal, sales of its fluticasone propionate nasal spray dropped from $23 million in the 3rd quarter of the 2013 fiscal year to only $10.9 million for the same period in 2014. The… Read more . . .
-
Abstracts should be submitted by August 29, 2014 through either: 1) Online submission (IDDA website is under construction and will be announced upon completion.) 2) Email submission to: iddchina@126.com Abstracts should be no more than… Read more . . .
-
Device manufacturer Gerresheimer has announced that it is adding 60,000 sq ft to its production facility in Peachtree City, GA in order to accommodate increased demand for inhalers and other plastic medical devices. Approximately 40,000… Read more . . .
-
Verona Pharma has announced that it is looking to raise up to £14 million through a placing, subscription, and open offer of more than 630 million new ordinary shares, conditioned on approval of shareholders. A… Read more . . .
-
Some day in the not-too-distant future, a dry powder inhaler once used to deliver insulin may help Parkinson’s patients overcome some of the most debilitating symptoms of the disease. Back in 2008, in the wake… Read more . . .
-
Teva has announced the US launch of Adasuve loxapine inhalation powder for the treatment of agitation in schizophrenic or bipolar patients. The company licensed Adasuve from its developer, Alexza Pharmaceuticals in May 2013. Alexza’s Staccato… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.